Literature DB >> 1423194

"Solid" variant of aneurysmal bone cyst (extragnathic giant cell reparative granuloma) in the axial skeleton and long bones. A study of its morphologic spectrum and distinction from allied giant cell lesions.

Y Oda1, M Tsuneyoshi, N Shinohara.   

Abstract

BACKGROUND: Giant cell reparative granuloma is generally considered to be a benign tumor-like bone lesion. Its involvement of axial skeleton and long bones is rare.
METHODS: Seven cases of extragnathic giant cell reparative granuloma (GCRG), which arose in the axial skeleton and long bones, were analyzed clinicopathologically and compared with allied lesions consisting of 31 cases of aneurysmal bone cyst (ABC) and 83 cases of giant cell tumor of bone (GCT).
RESULTS: These occurred in patients ranging in age from 8-36 years; two were in the vertebrae; two, in the clavicles; one, in a rib; one, in the humerus; and one in the tibia. None of the patients with GCRG had a recurrence despite incomplete resection. Its skeletal distribution and average associated patient age were similar to those of ABC. Histologically, they were characterized by florid fibroblastic proliferation with osteoclast-like giant cell-rich areas, stromal hemorrhage, and newly formed bone or osteoid trabeculae. The histologic features could be found around either the characteristic aneurysmal cysts or sinuses, although they were lacking any large blood-filled spaces.
CONCLUSIONS: The overlapping clinical and histologic features between GCRG and ABC and their similar biologic behavior represent related responses to an intraosseous hemorrhage. The authors prefer to use the term "solid variant of aneurysmal bone cyst" to describe this lesion.

Entities:  

Mesh:

Year:  1992        PMID: 1423194     DOI: 10.1002/1097-0142(19921201)70:11<2642::aid-cncr2820701113>3.0.co;2-#

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  17 in total

1.  Giant cell reparative granuloma of the nasal cavity.

Authors:  Jonathan M Morris; John I Lane; Robert J Witte; Dana M Thompson
Journal:  AJNR Am J Neuroradiol       Date:  2004-08       Impact factor: 3.825

2.  CT and MR imaging of giant cell granuloma of the craniofacial bones.

Authors:  J S Nackos; R H Wiggins; H R Harnsberger
Journal:  AJNR Am J Neuroradiol       Date:  2006-09       Impact factor: 3.825

3.  Temporal giant cell reparative granuloma: a reappraisal of pathology and imaging features.

Authors:  C Reis; J M Lopes; E Carneiro; A Vilarinho; R Portugal; F Duarte; J Fonseca
Journal:  AJNR Am J Neuroradiol       Date:  2006-09       Impact factor: 3.825

4.  Giant-cell tumors of the sphenoid bone in four children: radiological, clinical, and pathological findings.

Authors:  A L Weber; E B Hug; M W Muenter; H D Curtin
Journal:  Skull Base Surg       Date:  1997

5.  Pain and deformity of the index finger in a 41-year-old woman.

Authors:  Veronica A Diaz; Stephen E Vernon; E Anne Ouellette
Journal:  Clin Orthop Relat Res       Date:  2008-03-14       Impact factor: 4.176

6.  Orthopaedic . Radiology . Pathology Conference: painful ulnar lesion in a 16-year-old boy.

Authors:  George M Kontakis; Apostolos H Karantanas; Panayiotis J Papagelopoulos
Journal:  Clin Orthop Relat Res       Date:  2008-09-24       Impact factor: 4.176

7.  Giant cell reparative granuloma of posterior ethmoid: A case report.

Authors:  N H Bhalodiya; N Singh
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2005-10

8.  Commentary to: Giant cell reparative granuloma of the scapula: report of a case and literature review.

Authors:  Fiona Bonar
Journal:  Skeletal Radiol       Date:  2019-11-12       Impact factor: 2.199

9.  Solid aneurysmal bone cyst with pathologic bone fracture.

Authors:  C P Adler
Journal:  Skeletal Radiol       Date:  1995-04       Impact factor: 2.199

10.  First report of a solid variant of aneurysmal bone cyst in the os sacrum.

Authors:  Helen Vester; Bernd Wegener; Christoph Weiler; Andrea Baur-Melnyk; Volkmar Jansson; Hans Roland Dürr
Journal:  Skeletal Radiol       Date:  2009-07-15       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.